JHS Svendgaard Laboratories Ltd (JHS) — concall transcript | 31 March 2024

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
JHS targets 30-40% revenue growth and mid-teens EBITDA margins in FY25 with INR110 crore order book.
🔄 What Changed
Order book size (INR110 crores), capacity utilization target (70-80% in 2 years), and customer concentration reduced below 25%
🔮 What's Next
30-40% revenue growth and mid-teens EBITDA margins in FY25
💡 Investor Takeaway
Shareholders should note improving profitability and reduced customer concentration risk through strategic diversification.

JHS Svendgaard Laboratories reported FY24 earnings call highlights centered on margin recovery through price increases and customer diversification. Management targets 30-40% revenue growth and mid-teens EBITDA margins in FY25, supported by a INR110 crore order book. Key updates include new clients like Reliance and Unilever, resumption of institutional sales, and progress on the Talcum plant. Export sales rebounded with improved payment terms, while capacity utilization aims for 70-80% in two years. Past challenges with P&G due to market failures were addressed by reducing single-client dependency below 25%. Expansion into detergent and Ayurvedic segments is underway, with management emphasizing resilience and growth potential.

📄 View Original Announcement (PDF)

About JHS Svendgaard Laboratories Ltd (JHS)

Fast Moving Consumer Goods · FMCG · Listed on BSE

Market Cap: ₹68.44 Cr ROE: -1.1% ROCE: -1.1%

View full JHS stock details →

📡 Get AI alerts when JHS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JHS — Free

📊 More JHS filings

See all JHS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JHS files new disclosures

Track JHS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JHS — Free

Free account · 2 AI queries/day